Back to



Steve Forbes

Forbes Media

Chairman and Editor-in-Chief

Steve Forbes is chairman and editor-in-chief of Forbes Media. The company's flagship publication, Forbes, is the nation's leading business magazine, with a circulation of more than 900,000. Forbes combined with Forbes Asia, Forbes Europe, and the company's licensee editions together reach a worldwide audience of more than five million readers. has become one of the world's most influential Web sites, with more than 60 million unique visitors a month. Mr. Forbes writes editorials for Forbes under the heading of "Fact and Comment." A widely respected economic prognosticator, he is the only writer to have won the highly prestigious Crystal Owl Award four times. The prize was formerly given by U.S. Steel Corporation to the financial journalist whose economic forecasts for the coming year proved most accurate. He is the author of Reviving America: How Repealing Obamacare, Replacing the Tax Code, and Reforming The Fed will Restore Hope and Prosperity, Money: How the Destruction of the Dollar Threatens the Global Economy--and What We Can Do About It, How Capitalism Will Save Us: Why Free People and Free Markets Are the Best Answer in Today's Economy, co-authored by Elizabeth Ames; and Power Ambition Glory: The Stunning Parallels Between Great Leaders of the Ancient World and Today...and the Lessons You Can Learn, co-authored by John Prevas. He also wrote: Flat Tax Revolution: Using a Postcard to Abolish the IRS; and A New Birth of Freedom, a book of bold ideas for the new millennium. Mr. Forbes serves on the boards of The Ronald Reagan Presidential Foundation, the Heritage Foundation, and The Foundation for the Defense of Democracies.


Jeffrey Saut

Raymond James & Associates

Chief Investment Strategist

As Raymond James' chief investment strategist and a managing director of the firm's Equity Research department, Mr. Saut provides timely and insightful market commentary to Raymond James financial advisors, their clients, and institutional clients through daily strategy calls and writings, his weekly written commentary, as well as local and national media appearances. A disciple of the markets for more than 46 years, he possesses a breadth of experience in the field few can match. He was managing director of research at Roney & Co. when it became part of Raymond James in 1999. Prior to that, he was managing director of equity capital markets for Sterne, Agee & Leach.


John McCamant

Medical Technology Stock Letter


John McCamant joined the Medical Technology Stock Letter as associate editor in 1987 and was named editor of this leading investment newsletter in August 2000. He has spent 25 years on the front lines of biotechnology investing. As an equities analyst for the American Healthcare Fund, Mr. McCamant uncovered investment opportunities and guided investment strategy. At Burrill & Company, a San Francisco-based private merchant bank, he was a lead in raising $75 million for a venture capital fund. Mr. McCamant has established an extensive network that includes contacts throughout the investment banking and venture capital communities. His expertise in biotechnology investments is a subject of media interest, and he is frequently consulted and quoted by The Washington Post, BusinessWeek, Reuters, Bloomberg, and Marketwatch.


Marilyn Cohen

Envision Capital Management, Inc.

President & CEO

Marilyn Cohen is one of the country's top bond managers. She began her financial career as a securities analyst at William O'Neil & Co., moved into bond brokerage at Cantor Fitzgerald, Inc., then founded Envision Capital Management 22 years ago. As Envision's CEO, Ms. Cohen and her company specialize in managing bond portfolios for individuals. During this same 22 years, she has written the bond column appearing in Forbes magazine. Ms. Cohen is the author of four books, most recently, The Little Bond eBooklet: Must-Knows About Your Bond Portfolio. She is a popular guest on CNBC, FOX Business News, PBS and each of the major broadcast networks. Her comments--stated in plain English--guide individuals through the inner workings of the bond market.


Leslie Cho

Cleveland Clinic


Leslie Cho, MD, is director of Cleveland Clinic's Women's Cardiovascular Center. She is also section head of Preventive Cardiology and Rehabilitation in the Robert and Suzanne Tomsich Department of Cardiovascular Medicine at Cleveland Clinic. Her specialty interests focus on general cardiology, heart disease, and peripheral arterial and vascular disease and their attendant therapies and treatments. Dr. Cho specializes in heart disease in women. She received her undergraduate degree in interdisciplinary studies from the University of California, Los Angeles, graduating cum laude. Dr. Cho received her medical degree from the University of Chicago Pritzker School of Medicine and took her residency in internal medicine at the University of Washington Medical Center where she received the John Humphrey Award as Most Outstanding Internal Medicine Resident. Her clinical training continued when she accepted a fellowship in cardiology, followed by a fellowship in interventional cardiology and peripheral disease, both from Cleveland Clinic.


Matt Kalaycio

Cleveland Clinic

Chairman, Department of Hematology and Medical Oncology

Matt Kalaycio, MD, FACP, is chairman of the Department of Hematology and Medical Oncology at Cleveland Clinic's main campus. Dr. Kalaycio holds a joint appointment in Cleveland Clinic's Transplant Center. In addition to being a professor in the Cleveland Clinic Lerner College of Medicine of Case Western Reserve University, he is board certified in hematology. Dr. Kalaycio's clinical interests are in leukemia and stem cell transplantation. He was co-chairman of the Chronic Leukemia Working Committee of the Center for International Blood and Marrow Transplant Research (CIBMTR). His work has been published in numerous scientific publications including Bone Marrow Transplantation, Journal of Clinical Oncology, and Leukemia. He also is the editor of a book, Biologic Therapy of Leukemia, and co-editor of Clinical Malignant Hematology. Dr. Kalaycio is the editor-in-chief of Hematology News and is on the editorial board of Biology of Blood and Marrow Transplantation. Currently, he serves on the Board of Directors of the National Comprehensive Cancer Network (NCCN). Dr. Kalaycio received his degree from West Virginia University School of Medicine in Morgantown. He completed his residency in internal medicine at Mercy Hospital of Pittsburgh and fellowships in hematology and medical oncology and bone marrow transplantation at Cleveland Clinic.


Brian Griffin

Cleveland Clinic

Section Head, Cardiovasular Imaging

Brian Griffin, MD, has been a cardiologist at the Cleveland Clinic in Cleveland, Ohio, since 1993. He is the head of the section of Cardiovascular Imaging in the Heart & Vascular Institute since 2012. Prior to this, he was director of the Cardiovascular Disease Training Program since 1994. From 2003-2006, and again from 2016, he has been the vice chairman, Department of Cardiovascular Medicine at Cleveland Clinic, and has held the John and Rosemary Brown Endowed Chair in Cardiovascular Medicine at Cleveland Clinic since 2007. Dr. Griffin is the author of more than 300 publications in cardiology and has edited four cardiology textbooks. The Manual of Cardiovascular Medicine that he edits is in its 4th edition and has been translated into Chinese, Spanish, Greek, and Portuguese and was voted Cardiology Book of the Year in the British Medical Association Book Awards in 2013. He received the Stoke's Medal of the Irish Cardiac Society in 2002 and was the recipient of the Medtronic Award for Medicine, Nursing, and Health Sciences from the National University of Ireland Galway in 2011. He is an expert on valvular heart disease, echocardiography, radiation heart disease, and general clinical cardiology.


Kristin Kirkpatrick

Cleveland Clinic

Manager, Wellness Nutrition Services

Kristin Kirkpatrick is the manager of Wellness Nutrition Services at the Cleveland Clinic Wellness Institute, in Cleveland, Ohio. She presents nationally, is an award-winning dietitian, a bestselling author, and a regular television guest on both local and national shows such as the TODAY show and the Dr. Oz show and has contributed to several national magazines and newspapers such as The New York Times, The Wall Street Journal, TIME, Runner's World, and Women's Health. The Huffington Post named her "one of 25 diet and nutrition experts you need to follow on Twitter." She has over 17 years of experience in the health management area, holds an MS in health promotion management from American University and a BA in political science from The George Washington University. She is licensed as a registered dietitian in the state of Ohio. In May, 2012, Ms. Kirkpatrick received the Ohio Outstanding Dietetic Educator of the year award, and in 2013, received alumni of the year from her high school Gilmour Academy. She is the author of the bestselling book, Skinny Liver: A Proven Program to Prevent and Reverse the New Silent Epidemic--Fatty Liver Disease under DaCapo publishing, a division of Hachette.


John Buckingham

The Prudent Speculator


John Buckingham of AFAM Capital lends his over 30 years of investment management experience to two crucial leadership positions. He serves as the editor of The Prudent Speculator, which has been a top-ranked investment newsletter, in terms of total return performance, many times over. Additionally, he serves as the chief investment officer of AFAM Capital, a role he's held since 1990, leading a team that scrutinizes thousands of stocks for money management clients. He is also the company's largest shareholder. Mr. Buckingham started at AFAM Capital in 1987, forging his own path within the firm, and working and learning alongside the late Al Frank. This level of expertise and knowledge often sees John featured in Barron's, The Wall Street Journal, and Forbes, as well as frequently contributing to CNBC, Bloomberg, and Fox Business News.


Call and speak with an experienced Cruise Specialist who can provide world-class service and expertise answering your questions and booking your voyage.

Talk to an agent: 1-800-530-0770